+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Etodolac"

Global and Chinese Etodolac Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Etodolac Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 138 Pages
  • China, Global
From
Etodolac (CAS 41340-25-4) Global Market Research Report 2024 - Product Thumbnail Image

Etodolac (CAS 41340-25-4) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Etodolac is an analgesic drug used to treat pain and inflammation. It belongs to the class of non-steroidal anti-inflammatory drugs (NSAIDs) and is available in both oral and topical forms. It is commonly used to treat mild to moderate pain, such as headaches, muscle aches, and menstrual cramps. It is also used to reduce fever and inflammation associated with arthritis and other conditions. Etodolac is generally well-tolerated, but it can cause side effects such as nausea, vomiting, and stomach upset. The Etodolac market is a subset of the larger analgesics market. It is a competitive market, with many different brands and formulations available. Etodolac is often used as an alternative to other NSAIDs, such as ibuprofen and naproxen, due to its lower risk of side effects. Some companies in the Etodolac market include Pfizer, Novartis, Merck, and Mylan. Show Less Read more